Kroeger Christopher A. (CIK 1658918) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-18). Recent activity: Sell MPLT (118,037 shares), Sell MPLT (198 shares), Sell MPLT (14,880 shares), Sell MPLT (5,220 shares), Sell MPLT (29,624 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 118,037 | $3.2M |
| 2026-05-18 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 198 | $5,574 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 14,880 | $423,634 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 5,220 | $152,163 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 29,624 | $814,068 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 1,582 | $45,182 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 3,205 | $93,586 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 342 | $9,429 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 877 | $25,170 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 6,871 | $206,405 |
| 2026-05-11 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 5,890 | $179,998 |
| 2026-04-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 9,135 | $246,006 |
| 2026-04-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 2,477 | $66,904 |
| 2026-04-17 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 7,575 | $208,237 |
| 2026-02-09 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Buy | 23,145 | $0 |
| 2026-01-29 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Sell | 204,146 | $3.7M |
| 2025-10-28 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Buy | 225,693 | $0 |
| 2025-10-28 | MapLight Therapeutics, Inc. (MPLT) | Chief Executive Officer | Buy | 3,895 | $0 |
Source: SEC Form 4 filings · as of 2026-05-18